Effect of amino groups of mesoporous silica nanoparticles on CpG oligodexynucleotide delivery
Source abstract
Abstract
In this study, we proposed to modify mesoporous silica nanoparticles (MSNs) with 3-aminopropyltriethoxysilane (NH2-TES), aminoethylaminopropyltriethoxysilane (2NH2-TES) and 3-[2-(2-aminoethylamino)ethylamino] propyl-trimethoxysilane (3NH2-TES) for binding of cytosine-phosphate-guanosine oligodexynucleotides (CpG ODN), and investigated the effect of different amino groups of MSNs on the CpG ODN delivery. Serum stability, in vitro cytotoxicity, and cytokine interleukin-6 (IL-6) induction by MSN-NH2/CpG, MSN-2NH2/CpG and MSN-3NH2/CpG complexes were investigated in detail. The results showed that three kinds of aminated-MSN-based CpG ODN delivery systems had no cytotoxicity to RAW264.7 cells, and binding of CpG ODN to MSN-NH2, MSN-2NH2 and MSN-3NH2 nanoparticles enhanced the serum stability of CpG ODN due to protection by the nanoparticles. However, three aminated MSN-based CpG ODN delivery systems exhibited different CpG ODN delivery efficiency, and MSN-NH2/CpG complexes had the highest ability to induce IL-6 secretion.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: RNA Interference and Gene Delivery · Advanced biosensing and bioanalysis techniques · Immune Response and Inflammation
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (44)
Show source-provided references
1. 10.1002/cplu.20140236910.1002/cplu.201402369 ↗
2. 10.1146/annurev.immunol.20.100301.06484210.1146/annurev.immunol.20.100301.064842 ↗
3. 10.2147/IJN.S3019710.2147/IJN.S30197 ↗
4. 10.1038/374546a010.1038/374546a0 ↗
5. 10.1038/nri132910.1038/nri1329 ↗
6. 10.1038/nrd205910.1038/nrd2059 ↗
7. 10.2165/11316930-000000000-0000010.2165/11316930-000000000-00000 ↗
8. 10.1016/j.addr.2008.12.00710.1016/j.addr.2008.12.007 ↗
9. 10.1016/j.addr.2008.12.01210.1016/j.addr.2008.12.012 ↗
10. 10.1002/eji.20032403210.1002/eji.200324032 ↗
11. Sands H · Mol. Pharmacol. · 1994 · 45 · 93210.1016/S0026-895X(25)10208-3 ↗
12. 10.1038/nm98710.1038/nm987 ↗
13. Brown D A · J. Biol. Chem. · 1994 · 269 · 2680110.1016/S0021-9258(18)47090-1 ↗
14. 10.1016/S0167-4781(99)00140-210.1016/S0167-4781(99)00140-2 ↗
15. 10.1002/anie.20110518710.1002/anie.201105187 ↗
16. 10.1039/c3cc41972j10.1039/c3cc41972j ↗
17. 10.1016/j.msec.2013.04.01710.1016/j.msec.2013.04.017 ↗
18. 10.1039/C4RA05468G10.1039/C4RA05468G ↗
19. 10.1039/c1cs15246g10.1039/c1cs15246g ↗
20. 10.1039/C2BM00085G10.1039/C2BM00085G ↗
21. 10.1038/359710a010.1038/359710a0 ↗
22. 10.1002/anie.20060448810.1002/anie.200604488 ↗
23. 10.1016/j.jinorgbio.2007.12.02810.1016/j.jinorgbio.2007.12.028 ↗
24. 10.1021/jp201017e10.1021/jp201017e ↗
25. 10.1246/bcsj.2011002710.1246/bcsj.20110027 ↗
26. 10.1166/jnn.2013.733910.1166/jnn.2013.7339 ↗
27. 10.1039/c3nr00294b10.1039/c3nr00294b ↗
28. 10.1002/adfm.20140240810.1002/adfm.201402408 ↗
29. 10.1039/b904197d10.1039/b904197d ↗
30. 10.1088/0957-4484/25/5/05570110.1088/0957-4484/25/5/055701 ↗
31. 10.1002/jbm.a.3446610.1002/jbm.a.34466 ↗
32. 10.1002/ppsc.20120008910.1002/ppsc.201200089 ↗
33. 10.1111/j.1365-2567.2007.02762.x10.1111/j.1365-2567.2007.02762.x ↗
34. 10.1016/j.biomaterials.2009.06.05310.1016/j.biomaterials.2009.06.053 ↗
35. 10.1038/srep0053410.1038/srep00534 ↗
36. 10.1016/j.micromeso.2014.11.00710.1016/j.micromeso.2014.11.007 ↗
37. 10.1021/mp500385n10.1021/mp500385n ↗
38. 10.1021/la500746e10.1021/la500746e ↗
39. 10.1063/1.135603010.1063/1.1356030 ↗
40. 10.1016/j.jconrel.2004.02.02210.1016/j.jconrel.2004.02.022 ↗
41. 10.1002/anie.20120319310.1002/anie.201203193 ↗
42. 10.1002/smll.20130090310.1002/smll.201300903 ↗
43. 10.1111/vde.1205610.1111/vde.12056 ↗
44. 10.1016/j.micromeso.2005.06.01510.1016/j.micromeso.2005.06.015 ↗